推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Current Neuropharmacology

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 CURR NEUROPHARM最新评论:同问 (2023-07-23)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Current Neuropharmacology期刊基本信息Hello,您是该期刊的第30079位访客

基本信息 登录收藏
期刊名字Current NeuropharmacologyCurrent Neuropharmacology

CURR NEUROPHARMACOL
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.4
50人评分
我要评分

声誉
8.8

影响力
6.3

速度
7.0

期刊ISSN1570-159X
微信扫码收藏此期刊
E-ISSN1875-6190
2022-2023最新影响因子
(数据来源于搜索引擎)
5.3 点击查看影响因子趋势图
实时影响因子 截止2023年12月27日:4.108
2022-2023自引率1.90%点击查看自引率趋势图
五年影响因子7.9
h-index 58
CiteScore
CiteScoreSJRSNIPCiteScore排名
9.401.1681.566
学科分区排名百分位
大类:Medicine
小类:Pharmacology (medical)
Q121 / 260
大类:Medicine
小类:Psychiatry and Mental Health
Q145 / 531
大类:Medicine
小类:Neurology
Q120 / 175
大类:Medicine
小类:Neurology (clinical)
Q143 / 373
大类:Medicine
小类:Pharmacology
Q145 / 301

期刊简介
Current Neuropharmacology aims to provide current, comprehensive/mini reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.

The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.
期刊官方网站http://benthamscience.com/journal/index.php?journalID=cn
期刊投稿网址http://bsp-cms.eurekaselect.com/index.php/CN
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Current Neuropharmacology的语言要求,还能让Current Neuropharmacology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Current Neuropharmacology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR
出版商Bentham Science Publishers B.V.
涉及的研究方向医学-神经科学
出版国家或地区ENGLAND
出版语言English
出版周期Quarterly
出版年份2003
年文章数 149点击查看年文章数趋势图
Gold OA文章占比5.23%
研究类文章占比:
文章 ÷(文章 + 综述)
18.12%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:NEUROSCIENCES
类别:SCIE
Q162/272
学科:PHARMACOLOGY & PHARMACY
类别:SCIE
Q155/277
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区2区2区
PHARMACOLOGY & PHARMACY
药学
2区2区2区
NEUROSCIENCES
神经科学
1区3区3区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区2区2区
NEUROSCIENCES
神经科学
2区4区2区
PHARMACOLOGY & PHARMACY
药学
4区1区2区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 2区2区4区
PHARMACOLOGY & PHARMACY
药学
1区3区1区
NEUROSCIENCES
神经科学
1区4区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1570-159X%5BISSN%5D
平均审稿速度网友分享经验:
>12周,或约稿
平均录用比例网友分享经验:
较易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Current Neuropharmacology顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Current Neuropharmacology期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Current Neuropharmacology中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Current Neuropharmacology上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    NATURE REVIEWS NEUROSCIENCE35732.40
    NATURE NEUROSCIENCE37543.90
    Neuron43026.90
    TRENDS IN NEUROSCIENCES26925.70
    Molecular Neurodegeneration6625.00
    Annual Review of Neuroscience22424.40
    Journal of Neuroinflammation9215.00
    PROGRESS IN NEUROBIOLOGY21215.20
    GLIA14814.00
    Journal of Neuroimmune Pharmacology6412.20
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE599667
    BIOMATERIALS512545
    BIOMEDICINE & PHARMACOTHERAPY461621
    Journal of Materials Chemistry B458273
    Frontiers in Pharmacology448063
    Frontiers in Immunology418941
    JOURNAL OF ETHNOPHARMACOLOGY403392
    COLLOIDS AND SURFACES B-BIOINTERFACES402990
    Frontiers in Oncology382346
    Acta Biomaterialia374480
  •  

    Current Neuropharmacology Current Neuropharmacology
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis

    Author: Yang, Mi; Wang, Chunzhi; Zhao, Guocheng; Kong, Di; Liu, Liju; Yuan, Shuai; Chen, Wei; Feng, Can; Li, Zezhi
    Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 2, pp. 340-352. DOI: 10.2174/1570159X20666220706101021
        PubMed      DOI
    2.New Insights of Early Brain Injury after Subarachnoid Hemorrhage: A Focus on the Caspase Family

    Author: Wang, Xiaoyu; Xu, Penglei; Liu, Yibo; Wang, Zefeng; Lenahan, Cameron; Fang, Yuanjian; Lu, Jianan; Zheng, Jingwei; Wang, Kaikai; Wang, Wei; Zhou, Jingyi; Chen, Sheng; Zhang, Jianming
    Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 2, pp. 392-408. DOI: 10.2174/1570159X20666220420115925
        PubMed      DOI
    3.Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial

    Author: Tang, Yiguo; Wu, Yulu; Li, Xiaojing; Hao, QinJian; Deng, Wei; Yue, Weihua; Yan, Hao; Zhang, Yamin; Tan, Liwen; Chen, Qi; Yang, Guigang; Lu, Tianlan; Wang, Lifang; Yang, Fude; Zhang, Fuquan; Yang, Jianli; Li, Keqing; Lv, Luxian; Tan, Qingrong; Zhang, Hongyan; Ma, Xin; Li, Lingjiang; Wang, Chuanyue; Ma, Xiaohong; Zhang, Dai; Yu, Hao; Zhao, Liansheng; Ren, Hongyan; Wang, Yingcheng; Zhang, Guangya; Li, Chuanwei; Du, Xiangdong; Hu, Xun; Li, Tao; Wang, Qiang
    Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 2, pp. 424-436. DOI: 10.2174/1570159X21666221118164612
        PubMed      DOI
    4.Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week Study

    Author: Su, Xiuru; Wang, Xuan; Pan, Xiuling; Zhang, Xuan; Lu, Xinyan; Zhao, Long; Chen, Yingnan; Shang, Yujie; Zhu, Lin; Lu, Shulan; Zhu, Xiaolin; Wu, Fengchun; Xiu, Meihong
    Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 2, pp. 417-423. DOI: 10.2174/1570159X20666220524123315
        PubMed      DOI
    5.Neuronavigated Repetitive Transcranial Stimulation Improves Neurocognitive Functioning in Veterans with Schizophrenia: A Possible Role of BDNF Polymorphism

    Author: Su, Xiuru; Liu, Haixia; Wang, Xuan; Pan, Xiuling; Zhang, Xuan; Lu, Xinyan; Zhao, Long; Chen, Yingnan; Shang, Yujie; Wu, Fengchun; Xiu, Meihong
    Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 1, pp. 142-150. DOI: 10.2174/1570159X20666220803154820
        PubMed      DOI
    6.Energy Crisis Links to Autophagy and Ferroptosis in Alzheimer's Disease: Current Evidence and Future Avenues

    Author: He, Da-Long; Fan, Yong-Gang; Wang, Zhan-You
    Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 1, pp. 67-86. DOI: 10.2174/1570159X20666220817140737
        PubMed      DOI
    7.Epilepsy and Autism Spectrum Disorder (ASD): The Underlying Mechanisms and Therapy Targets Related to Adenosine

    Author: Guo, Mengyi; Xie, Pandeng; Liu, Siqi; Luan, Guoming; Li, Tianfu
    Journal: CURRENT NEUROPHARMACOLOGY. 2023; Vol. 21, Issue 1, pp. 54-66. DOI: 10.2174/1570159X20666220706100136
        PubMed      DOI
    8.Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms.

    Author: Hu LY1, Mi WL1, Wu GC1, Wang YQ1, Mao-Ying QL1.
    Journal: Curr Neuropharmacol. 2019;17(2):184-196. doi: 10.2174/1570159X15666170915143217.
        PubMed      DOI
    9.The Role of CXCR3 in Neurological Diseases.

    Author: Zhou YQ1,2, Liu DQ1,2, Chen SP1,2, Sun J1,2, Zhou XR3, Xing C4, Ye DW3, Tian YK1,2.
    Journal: Curr Neuropharmacol. 2019;17(2):142-150. doi: 10.2174/1570159X15666171109161140.
        PubMed      DOI
    10.Targeting Cytokines for Morphine Tolerance: A Narrative Review.

    Author: Liu DQ1,2, Zhou YQ1,2, Gao F1,2.
    Journal: Curr Neuropharmacol. 2019;17(4):366-376. doi: 10.2174/1570159X15666171128144441.
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity065.50
    Living Reviews in Relativity7565.50
    JOURNAL OF TRAVEL MEDICINE5119.60
    Military Medical Research030.10
    Advanced Composites and Hybrid Materials016.90
    INTERNATIONAL JOURNAL OF COMPUTER VISION17222.50
    Eurosurveillance9027.70
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE715.70
    Small Structures00.00
    Trends in Chemistry032.10


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共10条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451